Your browser doesn't support javascript.
loading
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown, Susan E; Moser, Carlee B; MacPhail, Patrick; Matining, Roy M; Godfrey, Catherine; Caruso, Stephanie R; Hosseinipour, Mina C; Samaneka, Wadzanai; Nyirenda, Mulinda; Busakhala, Naftali W; Okuku, Fred M; Kosgei, Josphat; Hoagland, Brenda; Mwelase, Noluthando; Oliver, Vincent O; Burger, Henriette; Mngqibisa, Rosie; Nokta, Mostafa; Campbell, Thomas B; Borok, Margaret Z.
Afiliación
  • Krown SE; AIDS Malignancy Consortium, New York, NY, USA. Electronic address: krowns@mskcc.org.
  • Moser CB; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA.
  • MacPhail P; Clinical HIV Research Unit, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa.
  • Matining RM; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA.
  • Godfrey C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Caruso SR; Frontier Science Foundation, Amherst, NY, USA.
  • Hosseinipour MC; UNC Project-Malawi, Lilongwe, Malawi; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Division of Infectious Diseases, Chapel Hill, NC, USA.
  • Samaneka W; Parirenyatwa Clinical Research Site, Harare, Zimbabwe.
  • Nyirenda M; Johns Hopkins Research Project, University of Malawi College of Medicine, Blantyre, Malawi.
  • Busakhala NW; Moi University School of Medicine, Eldoret, Kenya.
  • Okuku FM; Uganda Cancer Institute, Kampala, Uganda.
  • Kosgei J; Kenya Medical Research Institute, USA Medical Directorate for Africa/Kenya, Kericho, Kenya.
  • Hoagland B; Oswaldo Cruz Foundation, Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil.
  • Mwelase N; Clinical HIV Research Unit, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa.
  • Oliver VO; Kenya Medical Research Institute, Centre for Global Health Research, Centers for Disease Control and Prevention, Kisumu CRS, HIV-Research Branch, Kisumu, Kenya.
  • Burger H; Family Clinical Research Unit CRS, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa; Division of Radiation Oncology, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Mngqibisa R; Durban International Clinical Research Site, Enhancing Care Foundation, Durban, South Africa.
  • Nokta M; Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Campbell TB; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Borok MZ; Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Lancet ; 395(10231): 1195-1207, 2020 04 11.
Article en En | MEDLINE | ID: mdl-32145827

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma de Kaposi / Vincristina / Bleomicina / Infecciones Oportunistas Relacionadas con el SIDA / Antibióticos Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma de Kaposi / Vincristina / Bleomicina / Infecciones Oportunistas Relacionadas con el SIDA / Antibióticos Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido